The effects of patient education in asthma: A randomised, controlled trial;Effekter av astmaopplæring i en randomisert, kontrollert undersøkelse

Tidsskrift for den Norske Laegeforening

Volumn 122, Issue 28, 2002, Pages 2702-2706

  Gallefoss, Frode ^a   Bakke, Per S ^b  

^a Lungeseksjonen   (Norway)

^b Haukeland Universitetssykehus   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; ANTIASTHMATIC AGENT;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; NURSE; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSIOTHERAPIST; PRESCRIPTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; ADULT; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; ECONOMICS; FEMALE; FOLLOW UP; HEALTH SERVICES RESEARCH; LUNG VOLUME; MALE; METHODOLOGY; NORWAY; OUTCOME ASSESSMENT;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; NORWAY; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION; QUALITY OF LIFE; SELF CARE;

EID: 0037146513     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gallefoss F. The effects of patient education in asthma and COPD - A randomised, controlled trial. Doktoravhandling. Bergen: Medisinsk institutt, Universitetet i Bergen, 2001.
2. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention NHLBI/WHO workshop report (based on a March 1993 meeting) (NIH No 95-3659). Bethesda, MD: National Institutes of Health, 1995.
3. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156: 787-93.
4. Krahn MD, Berka C, Langlois P, Detsky AS. Direct and indirect costs of asthma in Canada, 1990. CMAJ 1996; 154: 821-31.
5. Weiss KB, Sullivan SD. Understanding the costs of asthma: The next step. CMAJ 1996; 154: 841-3.
6. Buist AS. Cost-effectiveness of asthma management strategies. Eur Respir Rev 1995; 5: 292-4.
7. Bone RC. Goals of asthma management: A step-care approach. Chest 1996; 109: 1056-65.
8. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995; 96: 707-870.
9. Kauppinen R, Sintonen H, Tukiainen H. One-year economic evaluation of intensive vs conventional patient education and supervision for selfmanagement of new asthmatic patients. Respir Med 1998; 92: 300-7.
10. Neri M, Migliori GB, Spanevello A, Berra D, Nicolin E, Landoni CV et al. Economic analysis of two structured treatment and teaching programs on asthma. Allergy 1996; 51: 313-9.
11. Gallefoss F, Bakke PS, Kjærsgaard P. Quality of life assessment after patient education in a randomized controlled study on asthma and COPD. Am J Respir Crit Care Med 1999; 159: 812-7.
12. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med 1999; 160: 2000-5.
13. Gallefoss F, Bakke PS. Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 279-87.
14. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998; 317: 1309-12.
15. Gallefoss F, Bakke PS. Cost-effectiveness of self-management in asthmatics: A 1-year followup randomized, controlled trial. Eur Respir J 2001; 17: 206-13.
16. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yemault JC. Lung volumes and forced ventilatory flows. Eur Respir J Suppl 1993; 16: 5-40.
17. Applied research and communications limited. The life quality of asthma. The Omnibus Interviews. London: Allen & Hanburys, 1991; 1-40.
18. Jonsson B. A health economist's view. Eur Respir Rev 1995; 5: 271-4.
19. Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB. National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care. Am J Respir Crit Care Med 1996; 154 (suppl): 84-95.
20. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-7.
21. DRG-liste. Oslo: Sosial- og helsedepartementet, 1994.
22. Normaltariffen. Oslo: Den norske lægeforening, 1994: 3.
23. Taraldset A. Legeforeningens undersøkelse om inntekter og kostnader i allmennpraksis og spesialistpraksis. Tidsskr Nor Lægeforen 1996; 116: 3052-4.
24. Anatomical Therapeutic Chemical (ATC) Classification Index Including Defined Daily Doses (DDDs) for Plain Substances. Genève: WHO Collaborating Centre for Drug Statistics Methodology, 1994.
25. Gjennomsnittlig Industriarbeiderlønn, Tabell 11. Oslo: Statistisk sentralbyrå, 1994.
26. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995; 14: 171-89.
27. Drummond MF, O'Brien B, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997.
28. Altman DG. Practical Statistics for Medical Research. London: Chapman & Hall, 1991.
29. Rutten-van Molken MP, Van Doorslaer EK, Jansen MC, Kerstjens HA, Rutten FF. Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 975-82.
30. Buxton MJ. The economics of asthma - An introduction. Eur Respir Rev 1995; 6: 105-7.
31. Torrance GW, Siegel JE, Luce BR. Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
32. Gallefoss F, Bakke PS, Wang IJ, Gilja ME, Gulsvik A. Smoking status, disease duration and educational level in females are related to asthma school participation. Eur Respir J 2000; 15: 1022-5.